Rich Milton Ramirez Dulay

Dr. Rich Milton Ramirez Dulay


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Studies in Fungi
Verified
Journal Article
Open access
PDF file
RDRich Milton Ramirez Dulay
Rich Milton Ramirez Dulay
Oudemansiella of Physalacriaceae, Agaricomycetes, Basidiomycota is widely distributed in tropical and subtropical regions, and are known as saprophytic macrofungi. Species of this genus are edible, flavorful, nutritious, and medicinal. Hence, there is increasing attention to the value of these under-utilized myko-resources. In this context, this status review aimed to provide a species checklist of Oudemansiella and their distribution worldwide, cultivation requirements for growth and production, nutritional and bioactive compositions, and biological properties. A total of 25 species of Oudemansiella was recorded in 31 countries in Asia, North and South America, Australia, Africa, and Europe. O. canarii was found to be the most widely distributed, followed by O. platensis, O. cubensis, O. melanotricha, O. submucida, and O. australis. China had the greatest number of reported Oudemansiella species. O. canarii was the most commonly cultivated species using agro-industrial wastes such as sugarcane bagasse, eucalyptus sawdust, cotton seed hull, corncob, sawdust, and rice straw. Oudemansiella species contain carbohydrates, protein, amino acids, crude fiber, crude fat, minerals, and bioactive compounds such as oudemansin A and B, dihydroxerulin, xerulinic acid, and strobilurin C. Extracts and isolated bioactive compounds from Oudemansiella were reported to exhibit antioxidant, antifungal, antimicrobial, cytotoxic properties, and anti-trypanosomatid infection. To the best of our knowledge, this review establishes the most comprehensive checklist of Oudemansiella species. The presented data can be used as valuable information for further exploration and exploitation of the maximum profitability of Oudemansiella species. This review also provides status, challenges, and research opportunities that will ignite attention among researchers and scientists worldwide.

1 January 2022 in International Journal of Medicinal Mushrooms
Verified
Journal Article
Closed access
PDF file
RDRich Milton Ramirez Dulay
Rich Milton Ramirez Dulay
BVBenigno C. Valdez
Benigno C. Valdez
SCSeemanti Chakrabarti
Seemanti Chakrabarti
BDBraham Dhillon
Braham Dhillon
ECEsperanza C. Cabrera
Esperanza C. Cabrera
RRRenato G. Reyes
Renato G. Reyes
Cancer is the second leading cause of death worldwide, and despite of the of the availability of the advanced chemical treatments, development of effective and safe alternatives derived from natural resources are still of high interest. Mushroom is one of the important resources of pharmacologically active cytotoxic compounds. In this paper, we report the cytotoxicity of ethanolic extracts of Oudemansiella canarii (Jungh.) Höhn. and Ganoderma lucidum (W. Curt.: Fr.) P. Karst. against nine hematologic malignant cells and describe their molecular mechanisms. Cell lines were exposed to varying concentrations of mushroom extracts for 48 h and the cell proliferation and apoptosis parameters were determined. Western blot analysis was performed to determine the extract-induced changes in the level of apoptosis-related proteins in cancer cell lines and patient-derived mononuclear cells. Results revealed that O. canarii and G. lucidum extracts exhibited cytotoxicity with IC50 values of 26.8-66.0 ppm and 48.1-78.4 ppm, respectively, in all the cancer cell lines used. Mushroom extracts inhibited cell proliferation by 57.3-72.5% (O. canarii) and 44.2-67.4% (G. lucidum), which correlates to the activation of apoptosis as indicated by increased annexin V positivity, cells in sub G0/G1 phase and production of reactive oxygen species, and decreased mitochondrial membrane potential. Western blot analysis showed increase in the level of apoptotic markers (cleaved PARP1, cleaved caspase 3 and phosphorylation of histone 2AX) and activation of the stress-activated protein kinase (SAPK/JNK) signaling pathway. The extract-activated apoptosis was also observed in mononuclear cells isolated from the peripheral blood of leukemia and lymphoma patients. In conclusion, activation of pro-apoptotic markers is one of the major mechanisms of the cytotoxicity of O. canarii and G. lucidum extracts against hematologic malignant cells.

1 January 2023 in Journal of Applied Pharmaceutical Science
Verified
Journal Article
Open access
PDF file
JAJanice S. Aguilar
Janice S. Aguilar
RDRich Milton Ramirez Dulay
Rich Milton Ramirez Dulay
SKSofronio P. Kalaw
Sofronio P. Kalaw
RRRenato G. Reyes
Renato G. Reyes
Pycnoporus sanguineus is a species of mushroom in the Philippines with promising nutritional and pharmacological potentials. In this study, the optimum nutritional and physical growth preferences of P. sanguineus in submerged conditions were established and the biological activities of ethanol extract of its mycelia were determined. The highest yield (100.13 mg/30ml) was produced in rice bran broth with a wide range of pH concentration. Biomass production was favored under 28°C, in lighted and agitated conditions with 147.20 mg/30 ml, 168.47 mg/30 ml, and 413.30 mg/30 ml, respectively. The extract inhibited the growth of Staphylococcus aureus while no antibacterial activity was observed in Escherichia coli. It was found toxic to brine shrimp with an LC50 value of 190.55 μg/ml. Exposure of zebrafish embryos to the extract caused delayed growth resulting in a lower hatching rate. Growth retardation was the most noticeable teratogenic effect of the extract after 48 hours and high mortality rates were observed in high extract concentrations. This study suggests that the optimum biomass yield of P. sanguineus can be achieved when incubated under the most favorable conditions. Mycelia of P. sanguineus could be a valuable resource of antibacterial and cytotoxic compounds.

25 June 2026 in Antibiotics
Verified
Journal Article
Open access
PDF file
JFJamil Allen Gamboa Fortaleza
Jamil Allen Gamboa Fortaleza
KCKevin Smith Puno Cabuhat
Kevin Smith Puno Cabuhat
Herminiño LagunzadHerminiño Lagunzad
Herminiño Lagunzad
WPWarren B. Panizales
Warren B. Panizales
JCJowi Tsidkenu Pili Cruz
Jowi Tsidkenu Pili Cruz
JNJose Jurel M. Nuevo
Jose Jurel M. Nuevo
Antimicrobial resistance and persistent biofilm-associated infections have renewed interest in bacteriophages as alternatives or complements to conventional antibiotics. However, broader therapeutic adoption remains constrained by slow phage discovery, incomplete genome characterization, narrow host range, complex therapeutic matching, and manufacturing variability. Artificial intelligence (AI) offers computational approaches that may help address several of these limitations. This comprehensive narrative review discusses current AI applications across the bacteriophage pipeline, including metagenomic phage discovery, genome annotation, phage–host interaction prediction, personalized phage selection, cocktail optimization, and phage–antibiotic combination design. The review also examines AI-assisted synthetic biology approaches, including receptor-binding protein redesign, CRISPR-enabled engineering, generative genome design, and biosafety screening, as well as emerging applications in bioprocess optimization, yield prediction, purification analytics, quality assurance, and supply-chain management. Current evidence suggests that AI may accelerate phage identification, improve host-range prediction, support therapeutic optimization, and strengthen manufacturing consistency, potentially facilitating the transition of phage therapy from individualized rescue interventions toward more scalable antimicrobial platforms. Nevertheless, major limitations remain, including fragmented, taxonomically biased datasets; limited external validation; restricted interpretability; privacy concerns; biosafety oversight; and evolving regulatory frameworks. Future progress will depend on standardized datasets, multimodal validation, scalable manufacturing systems, experimental and clinical verification, and coordinated regulatory development.

31 December 2018 in CLSU International Journal of Science and Technology
Verified
Journal Article
Open access
PDF file
MSMaricris M. Sogan
Maricris M. Sogan
JMJason Arnold L. Maslang
Jason Arnold L. Maslang
RDRich Milton Ramirez Dulay
Rich Milton Ramirez Dulay
Myco-Chemicals and Teratogenic Activity of Wild Mushroom Trichaleurina celebica from Mt. Palali, Quezon, Nueva Vizcaya, Luzon Island, Philippines